ASJC Scopus Subject Areas (4053)
Medicine(all) (890)
Hematology (17)
Number of items at this level: 17.
B
Recommendation on the nomenclature for anticoagulants: updated communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Commitee on the Control of Anticoagulation. (2023)
Geoffrey D Barnes,
Walter Ageno,
Lana A Castellucci,
Thita Chiasakul,
Renee Eslick,
Jose Luis Ferreiro,
David Gailani,
Diana Gorog,
Gregory Y H Lip,
Leslie Raffini,
Suely M Rezende,
Jeffrey I Weitz
and
Adam Cuker
C
Erdafitinib in BCG-treated high risk non-muscle invasive bladder cancer. (2024)
James W.F. Catto,
Ben Tran,
Morgan Roupret,
Juergen E. Gschwend,
Yohann Loriot,
Hiroyuki Nishiyama,
Joan P. Redorta,
Siamak Daneshmand,
Syed A. Hussain,
Hernan J Cutuli,
Giuseppe Procopio,
Valentina Guadalupi,
Nikhil Vasdev,
Vahid Naini,
Lauren Crow,
Spyros Triantos,
Mahadi Baig
and
Gary D. Steinberg
G
Thrombogenicity and Antithrombotic Strategies in Structural Heart Interventions and Nonaortic Cardiac Device Therapy—Current Evidence and Practice. (2019)
Tobias Geisler,
Rezo Jorbenadze,
Aron-Frederik Popov,
Karin L. Mueller,
Dominik Rath,
Michal Droppa,
Juergen Schreieck,
Peter Seizer,
Robert F. Storey,
Steen D. Kristensen,
Andrea Rubboli,
Diana Gorog,
Daniel Aradi,
Dirk Sibbing,
Kurt Huber,
Meinrad Gawaz
and
Jur Ten Berg
Comparison of De-escalation of DAPT Intensity or Duration in East Asian and Western Patients with ACS Undergoing PCI: A Systematic Review and Meta-analysis. (2023)
Diana Gorog,
Visvesh Jeyalan,
Rafaella I. L. Markides,
Eliano P Navarese,
Young-Hoon Jeong
and
Mohamed Farag
Haematological malignancy: are we measuring what is important to patients? A systematic review of quality of life instruments. (2019)
Pushpendra Goswami,
Yasmin Khatib
and
Sam Salek
The Burden of Disease in Pyruvate Kinase Deficiency: Patients' Perception of the Impact on Health-Related Quality of Life. (2018)
RF Grace,
L Cohen,
S Egan,
T Wells,
B Witherspoon,
A Ryan,
Mir-Saeed Shayegan Salek,
S Bodie
and
RJ Klaassen
MINOCA presenting with STEMI – incidence, aetiology and outcome in a contemporaneous cohort. (2019)
Ying X. Gue,
Natasha Corballis,
Alisdair Ryding,
Juan Carlos Kaski
and
Diana Gorog
Impact of Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy on Endogenous Fibrinolysis in Acute Coronary Syndrome: The VaLiDate-R study. (2024)
Ying X. Gue,
Vassilios Memtsas,
Rahim Kanji,
David Wellsted,
Amanda Busby,
Megan Smith,
Enric Vilar,
Alisdair Ryding,
Deepa J. Arachchillage
and
Diana Gorog
Rationale and design of "Can Very Low Dose Rivaroxaban (VLDR) in addition to dual antiplatelet therapy improve thrombotic status in acute coronary syndrome (VaLiDate-R)" study : A randomised trial modulating endogenous fibrinolysis in patients with acute coronary syndrome. (2019)
Ying X Gue,
Rahim Kanji,
David M Wellsted,
Manivannan Srinivasan,
Solange Wyatt
and
Diana A Gorog
K
Measuring thrombus stability at high shear, together with thrombus formation and endogenous fibrinolysis: first experience using the Global Thrombosis Test 3 (GTT-3). (2023)
Rahim Kanji,
Joshua Leader,
Vassilios Memtsas
and
Diana Gorog
Aspirin related platelet reactivity as a determinant of ten year survival in high risk non-ST segment elevation myocardial infarction (NSTEMI) patients. (2020)
Nazish Khan,
Mamas A. Mamas,
Alexandra Moss,
Diana A. Gorog,
Peter Nightingale,
Angel Armesilla,
Andrew Smallwood,
Shahzad Munir,
Saib Khogali,
Ben Wrigley
and
James M. Cotton
The East Asian Paradox : An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease. (2020)
Hyun Kuk Kim,
Udaya S. Tantry,
Sidney C. Smith,
Myung Ho Jeong,
Seung Jung Park,
Moo Hyun Kim,
Do Sun Lim,
Eun Seok Shin,
Duk Woo Park,
Yong Huo,
Shao Liang Chen,
Zheng Bo,
Shinya Goto,
Takeshi Kimura,
Satoshi Yasuda,
Wen Jone Chen,
Mark Chan,
Daniel Aradi,
Tobias Geisler,
Diana A. Gorog,
Dirk Sibbing,
Gregory Y.H. Lip,
Dominick J. Angiolillo,
Paul A. Gurbel
and
Young Hoon Jeong